Where does Euroimmun Medizinische Labordiagnostika AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Euroimmun Medizinische Labordiagnostika AG ranks #4,876 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Euroimmun Medizinische Labordiagnostika AG hold?

Euroimmun Medizinische Labordiagnostika AG holds 71 US utility patents granted between 2016 and 2025, spanning 28 technology areas.

What is Euroimmun Medizinische Labordiagnostika AG's Innovation Score?

Euroimmun Medizinische Labordiagnostika AG has an Innovation Score of 45.1 out of 100 (top 24% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Euroimmun Medizinische Labordiagnostika AG's patent grant rate increasing or decreasing?

Euroimmun Medizinische Labordiagnostika AG's recent grant velocity is +250% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Euroimmun Medizinische Labordiagnostika AG's patents?

Euroimmun Medizinische Labordiagnostika AG's patents average 10.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Euroimmun Medizinische Labordiagnostika AG

Q: What technology areas does Euroimmun Medizinische Labordiagnostika AG focus on?

Euroimmun Medizinische Labordiagnostika AG's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 46 patents, ranking #322 of 7,863 assignees active in that subclass. Grants appear in 28 CPC subclasses total.

Q: How is the Euroimmun Medizinische Labordiagnostika AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 71 granted patents across 28 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Euroimmun ranks #4,876 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 28 technology areas.

#4,876
of 49,997 US assignees by volume: Top 24%
by Innovation Score (45.1/100): 10.9
avg claims per patent: +250%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4876 · Foreign Corporation #4,876 · 71 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 71 grants
TOP-DECILE #4,876/49,997
PHOTO-FINISH Clarius Mobile Health
CPC-FOCUS G01N · 28 areas
INNOV-PAR 45.1/100
CLAIMS-PAR 10.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +250% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clarius Mobile Health Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Euroimmun’s 45.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.8 pts (33%) Velocity 5.1 pts (11%) Breadth 18.7 pts (41%) Claim depth 6.5 pts (14%)

Qualcomm Incorporated · highest

85
Basf Agro B V · near

45
Bradford · near

45
Doosan · near

45
Euroimmun Medizinisc… · this assignee

45
K-fee System · near

45
3D Lighting… · lowest

7

What this shows Euroimmun's Innovation Score is 45.1/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Euroimmun?

Each dot is one of Euroimmun’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Euroimmun’s own 10.9 claims/patent is at or below the 12.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Euroimmun vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Euroimmun's grants concentrate

Euroimmun Medizinische Labordiagnostika AG is a focused PatentsView assignee: 28 CPC subclasses with 64.8% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (16 grants) versus a trough of 1 in 2016. By volume, Euroimmun sits between Clarius Mobile Health Corp. and Guangdong Aoyun Technology Co., Ltd..

Euroimmun's three-year grant acceleration

From 2019–2021 to 2022–2024, Euroimmun Medizinische Labordiagnostika AG moved from 30 to 23 grants (0.77x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Clarius Mobile He…

71
Composecure

71
Domo

71
Engel Austria

71
FSP Technology

71
Freedom Scientific

71
Fujitsu Technolog…

71
Guangdong Aoyun T…

71
Euroimmun Medizin… ◀

71

What this shows Euroimmun holds 71 patents at rank #4,876, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Euroimmun

By rank, the assignees closest to #4,876 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Euroimmun's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Euroimmun, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Euroimmun ranks #322 of 7,863 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Basf Agro B.V. 45 Doosan Corporation 45 Bradford Company 45 K-fee System GMBH 45

Similar claim depth

Nearest assignees by average claims per patent (10.9 here).

Musco Corporation 10.9 avg Tohoku Pioneer Corporation 10.9 avg THE Gleason Works 10.9 avg NR Electric Co., Ltd. 10.9 avg

Euroimmun's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Euroimmun Medizinische Labordiagnostika AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	1.4%
2018	9	12.7%
2019	4	5.6%
2020	16	22.5%
2021	10	14.1%
2022	9	12.7%
2023	8	11.3%
2024	6	8.5%
2025partial year	8	11.3%

Which technologies does Euroimmun Medizinische Labordiagnostika AG patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 46

C07K - Peptides 18

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

G02B - Optical Elements, Systems OR Apparatus 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 7

G06T - Image Data Processing OR Generation, IN General 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

G06N - Computing Arrangements Based ON Specific Computational Models 4

G06V - Image OR Video Recognition OR Understanding 4

G06F - Electric Digital Data Processing 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 2

C12Y - Enzymes 2

Top 15 of 28 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Euroimmun Medizinische Labordiagnostika AG's patent record in context - here's where to go next.

Euroimmun Medizinische Labordiagnostika AG's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 64.8% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #4,876 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Euroimmun Medizinische Labordiagnostika AG against Clarius Mobile Health Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.